Send the following on WhatsApp
Continue to Chathttps://www.zonebourse.com/cours/action/BIO-PATH-HOLDINGS-INC-50916238/actualite/Bio-Path-Holdings-Inc-annonce-l-administration-d-une-dose-au-premier-patient-de-l-essai-clinique-d-42503408/?utm_source=whatsapp&utm_medium=social&utm_campaign=share